Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Bioactive Materials|July 8, 2022
Microenvironment-responsive electrocution of tumor and bacteria by implants modified with degenerate semiconductor filmDonghui Wang, Shun Xing, Feng Peng, et al.Small (Weinheim an Der Bergstrasse, Germany)|August 25, 2022
Layered Double Hydroxide-Based Micro "Chemical Factory" with Arsenic Processing and Screening Functions on Nitinol for Gallbladder Cancer TreatmentShun Xing, Donghui Wang, Haifeng Zhang, et al.Annals of Surgical Oncology|April 1, 2015
Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma PatientsZhiyong Shi, Jie Liu, Xiaohe Yu, et al.Hepatology Communications|January 6, 2026
Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised ratsHongbo Wang, Hai Li, Yang Liu, et al.Cancer|March 10, 2011
Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysisJuan Liu, Yefa Yang, Hongxin Zhang, et al.Bulletin Du Cancer|May 2, 2017
Polymorphisms in POLG were associated with the prognosis and mtDNA content in hepatocellular carcinoma patientsXiaoyu Long, Xiaoyan Wang, Yibing Chen, et al.Plos One|April 11, 2014
Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombusXiaohe Yu, Naijian Ge, Xu Guo, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 30, 2015
MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERKBeibei Zhai, Xiaofeng Zhang, Bin Sun, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2012
A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinomaBinyu Zhao, Jianguo Lu, Jikai Yin, et al.Plos One|April 26, 2014
Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratinJun Li, Lei Chen, Xiaofeng Zhang, et al.Pageof 4